Overview of the updated antiemetic guidelines for chemotherapy-induced nausea and vomiting

First Page		Document Content
Date: 2009-05-16 00:00:00 Antiemetics Chemotherapy-induced nausea and vomiting 5-HT3 antagonist Dolasetron Aprepitant Ondansetron Palonosetron Granisetron NK1 receptor antagonist Chemistry Medicine Organic chemistry		Overview of the updated antiemetic guidelines for chemotherapy-induced nausea and vomiting Add to Reading List Source URL: www.oncologypractice.com Download Document from Source Website File Size: 165,24 KB Share Document on Facebook

	P11444 - ASCO2014 MEC and HEC DocID: 1a4Ek - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 19OCx - View Document
	Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella DocID: 19AF1 - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 199Dl - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 1987o - View Document